The Joint

The Joint (JYNT) stock price, revenue and financials

View Company

$108.4 M

JYNT Mkt cap, 09-Nov-2018
The Joint EBIT (Q3, 2018)-191.3 K
The Joint Cash, 30-Sep-20185.6 M

The Joint Revenue Breakdown

Embed Graph

The Joint revenue breakdown by business segment: 58.3% from Franchise Operations and 41.7% from Corporate Clinics

The Joint Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

7.1m13.8m20.5m25.2m

Revenue growth, %

94%48%

Cost of goods sold

2.2m2.8m2.9m3.3m

Gross profit

4.9m11.0m17.6m21.9m

Gross profit Margin, %

68%80%86%87%

Sales and marketing expense

1.2m

General and administrative expense

5.1m15.4m22.1m18.1m

Operating expense total

6.3m18.2m26.5m18.1m

Depreciation and amortization

210.1k1.3m2.6m2.0m

EBIT

(9.3m)(15.0m)(3.2m)

EBIT margin, %

(67%)(73%)(13%)

Pre tax profit

(15.0m)(3.2m)

Income tax expense

235.9k(164.4k)(35.9k)

Net Income

(3.0m)(8.8m)(15.2m)

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.8m2.5m3.4m4.1m4.3m5.0m5.5m5.7m6.0m6.5m

Cost of goods sold

585.8k545.3k791.8k745.5k740.0k727.7k718.8k742.1k770.2k819.2k

Gross profit

1.2m2.0m2.6m3.4m3.5m4.2m4.8m4.9m5.2m5.7m

Gross profit Margin, %

68%78%77%82%83%85%87%87%87%87%

General and administrative expense

1.2m2.8m3.4m4.3m5.7m5.6m5.4m4.6m4.7m4.5m

Operating expense total

1.2m2.8m3.4m4.3m5.7m5.6m5.4m4.6m4.7m4.5m

Depreciation and amortization

278.5k421.4k575.5k637.1k695.6k578.0k503.2k468.8k

EBIT

(310.8k)(1.9m)(1.8m)(2.1m)(3.5m)(3.2m)(2.6m)(1.6m)(984.5k)(377.6k)

EBIT margin, %

(17%)(76%)(54%)(50%)(82%)(64%)(48%)(28%)(16%)(6%)

Pre tax profit

(1.9m)(3.5m)(3.2m)(2.6m)(1.6m)(1.0m)(367.7k)

Income tax expense

163.1k(6.1k)(44.4k)(73.5k)(14.3k)(40.6k)(2.6k)(36.1k)

Net Income

(202.4k)(1.9m)

The Joint Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

20.8m16.8m3.0m4.2m

Accounts Receivable

704.9k743.2k1.0m1.1m

Inventories

375.9k366.0k499.5k

Current Assets

23.4m19.0m5.7m6.7m

PP&E

1.1m7.1m4.7m3.8m

Goodwill

677.2k2.5m2.8m2.9m

Total Assets

28.6m33.4m17.1m16.9m

Accounts Payable

1.3m2.0m1.1m1.1m

Current Liabilities

4.3m7.5m5.9m5.0m

Total Liabilities

10.1m12.0m

Additional Paid-in Capital

21.4m35.3m36.4m37.2m

Retained Earnings

(5.0m)(13.8m)(29.0m)(32.3m)

Total Equity

15.6m20.7m6.9m4.9m

Financial Leverage

1.8 x1.6 x2.5 x3.5 x

Quarterly

USDQ3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

2.4m12.6m9.5m10.4m6.1m3.4m2.7m3.0m2.6m4.0m4.6m5.6m

Accounts Receivable

333.2k458.9k605.9k1.6m1.8m1.9m1.2m1.1m1.3m1.0m1.2m1.2m

Current Assets

5.5m14.5m11.6m13.6m9.5m7.4m5.8m5.6m5.4m6.6m7.2m8.4m

PP&E

794.4k2.7m3.6m8.0m8.2m7.5m4.4m4.1m3.8m3.7m3.7m3.3m

Goodwill

2.7m2.9m2.5m2.9m2.8m2.8m2.8m2.8m2.9m2.9m2.9m

Total Assets

9.8m24.0m22.5m28.7m25.3m22.1m16.5m16.1m15.6m18.2m18.8m19.8m

Accounts Payable

677.3k1.5m1.4m1.6m1.1m820.7k1.1m971.3k718.4k935.7k723.4k911.6k

Current Liabilities

4.0m5.3m5.9m6.2m5.4m5.3m5.0m4.6m4.1m5.7m5.6m6.2m

Total Liabilities

11.4m11.9m11.6m11.3m10.5m9.9m11.0m11.5m11.0m17.2m17.4m18.5m

Additional Paid-in Capital

1.6m21.7m22.1m35.5m36.1m36.3m36.6m36.7m36.8m37.5m37.9m38.0m

Retained Earnings

(2.4m)(8.8m)(10.4m)(17.3m)(20.6m)(23.2m)(30.6m)(31.6m)(32.0m)(36.3m)(36.4m)(36.6m)

Total Equity

(1.6m)12.2m10.9m17.4m14.7m12.3m5.5m4.6m4.7m1.1m1.3m1.3m

Financial Leverage

-6 x2 x2.1 x1.7 x1.7 x1.8 x3 x3.5 x3.3 x17.2 x14 x14.8 x

The Joint Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.0m)(8.8m)(15.2m)(3.3m)

Depreciation and Amortization

210.1k1.3m2.6m2.0m

Accounts Receivable

(369.5k)(100.0k)(999.5k)(124.1k)

Inventories

(352.2k)9.9k(133.5k)

Accounts Payable

1.0m(291.5k)(953.1k)(36.8k)

Cash From Operating Activities

(437.4k)(6.8m)(10.8m)156.4k

Purchases of PP&E

(659.3k)(4.1m)(1.6m)(449.2k)

Cash From Investing Activities

(2.1m)(10.0m)(2.7m)(372.9k)

Cash From Financing Activities

19.8m12.8m(239.9k)1.4m

Income Taxes Paid

420.3k

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(202.4k)(1.9m)(3.8m)(5.4m)(3.5m)(6.8m)(9.4m)(1.6m)(2.7m)(3.1m)(386.9k)(429.7k)(581.5k)

Depreciation and Amortization

52.8k122.6k401.1k822.5k575.5k1.2m1.9m578.0k1.1m1.6m387.4k792.4k1.2m

Accounts Receivable

333.2k241.6k94.7k(902.2k)(1.1m)(1.1m)(214.9k)(161.3k)(303.6k)90.8k104.9k(59.9k)

Accounts Payable

677.3k180.7k164.9k(1.2m)(1.1m)(1.2m)34.2k(83.6k)(336.5k)(133.0k)(384.5k)(225.8k)

Cash From Operating Activities

(2.5m)(4.0m)(5.8m)(8.1m)(10.3m)(1.3m)(734.7k)(1.4m)(33.1k)613.2k1.9m

Purchases of PP&E

(485.3k)(1.5m)(287.9k)(1.3m)(1.5m)(39.3k)(106.3k)(190.6k)(183.7k)(370.8k)(531.2k)

Cash From Investing Activities

(5.6m)(7.2m)(545.7k)(2.5m)(2.6m)(29.3k)(80.4k)(150.7k)(142.3k)(366.9k)(698.8k)

Cash From Financing Activities

(25.0k)(110.0k)(119.9k)(152.9k)(454.3k)952.8k852.0k1.2m23.3k141.6k286.7k

Interest Paid

135.01.4k

The Joint Ratios

USDY, 2018

Financial Leverage

14.8 x
Download Excel
Report incorrect company information

The Joint Operating Metrics

FY, 2014FY, 2015FY, 2016

Clinics

246 312 370

Patient Visits

2.17 m3.20 m4.10 m
Download Excel
Report incorrect company information

The Joint Employee Rating

3.8178 votes
Culture & Values
3.6
Work/Life Balance
3.6
Senior Management
3.5
Salary & Benefits
3.2
Career Opportunities
3.3
Source
View The Joint profile

Competitors

NeuroSky
Healthcare - Private
MoveWith
Healthcare - Private
OnSite Care
Healthcare - Private
E4 Health
Healthcare - Private
Compare competitors